Facility

The driving force behind our
proven and consistent quality.
Facility

Taking the ethos of ‘Creating a legacy of good’, we have leveraged and invested in our manufacturing facility that is globally approved to ensure timely delivery of highly dependable products.

This facility is a multiproduct – Granules, Tablets and Capsules – Our highly trained and experienced staff can customise any tablet or capsule, including packaging, that a customer requests, unpar­al­leled per­son­al­ized client care, trans­parency and a com­mit­ment to qual­ity are just some of the many advan­tages of part­ner­ing with our team of indus­try experts.

 

This facility is for Non-Beta Lactum and non-cephalosporin products. The special feature of this facility is its capability to manufacture 800 million tables a month.

Encore plant

Quality Control

To achieve consistent results, batch after batch, a central quality team has defined exhaustive SOPs which are constantly improved and optimized. This framework is built by leading experts from our Quality Control, Quality Assurance, Research and Development and Manufacturing departments.
At our plants, our focus is on constant monitoring, logging and optimizations. The circular process of Monitor, Assess, Realign and Repeat builds an iterative and constantly improving mechanism. Batch validation is done under stringent parameters to ensure large-scale reproducibility and regular team huddles bring a sense of cohesion across different departments.
By leveraging technology, we have reduced human intervention to wherever possible and have automated our processes that is decentralized, protected and logged.
Our overarching objective of making healthcare affordable is made possible by improving processes at our facilities. Avoiding wastage of product, service design activities, process innovation and agile responses have helped us reduce cost of manufacturing.

Clients

MERCK
HALEON
P&G
GSK
pfizer
BAYER

Associate Brands